Osteoporosis to cost €38.5bn in Europe’s ‘big 5’ by 2025

Osteoporosis to cost €38.5bn in Europe’s ‘big 5’ by 2025
The healthcare costs of rising European osteoporosis rates will reach €38.5bn by 2025 from €30.7bn in 2010, according to a study that reflected on the problem of an increasingly aged population.

The study, published in the Archives of Osteoporosis,​ notes that in 2010 there were 34,000 bone fracture-related deaths in the five biggest EU economies – Germany, the UK, France, Spain and Italy. Sweden was also included.

Half of those fractures were hip fractures and the report estimated that all fractures added up to a loss in quality-adjusted life years (QALY) of about 850,000.

The report highlights pharma and other interventions but notes patients only receive preventative advice about nutrients like calcium and vitamin D that have been backed by the European Food Safety Authority (EFSA) to boost bone health and even reduce the likelihood of falling in the elderly when patients were receiving, bone protective therapy”.

Increasing bone mass density testing is another intervention the report recommends.

It noted that that the healthcare cost exceeds that of for migraine, stroke, multiple sclerosis, and Parkinson’s disease, and registers at about the same level as rheumatoid arthritis.

Fracture rates will rise by 29% to 3.2 trillion in 2025.

“The assessment of best practices in prevention and treatment and the adoption of these across countries

can potentially result in significant reductions in the burden of osteoporosis,”​ the authors wrote.

They continued: In the few health economic analysis that have been published so far the results have shown that osteoporosis management programmes are a cost-effective intervention for the prevention of fractures. More evidence is needed both on the clinical outcomes and the cost-effectiveness of these programmes; however, it is likely that they will become more widely adopted in the future.”

Source:

Archives of Osteoporosis

DOI 10.1007/s11657-011-0060-1

‘Osteoporosis: Burden, health care provision and opportunities in the European Union’

Authors: O Ström, F Borgström, JA Kanis, J Compston, C Cooper, E V McCloskey, B Jönsson.

Related news

Show more

Related products

show more

Support a new era of active lifestyle consumers

Support a new era of active lifestyle consumers

Content provided by Lonza | 05-Nov-2024 | Product Brochure

Mobility is taking center stage for a new generation of consumers who understand that mobility and joint health are inextricably linked to long-term quality...

Unlock sensory innovation with AromatiQ™ technology

Unlock sensory innovation with AromatiQ™ technology

Content provided by Lonza | 20-Sep-2024 | Product Brochure

With 70% of consumers willing to pay a premium for a more enjoyable and memorable supplement experience, Lonza’s new AromatiQ™ technology enables brands...

Related suppliers

Follow us

Products

View more

Webinars